[English] 日本語
Yorodumi
- EMDB-25664: Local Refinement of the C-terminal Half of Leucine Rich Repeat Ki... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: EMDB / ID: EMD-25664
TitleLocal Refinement of the C-terminal Half of Leucine Rich Repeat Kinase 2 (LRRK2) (I2020T) tetramer bound to 11-protofilament microtubule in presence of MLi-2 kinase inhibitor
Map dataLocal refinement of LRRK2RCKW tetramer bound to 11-pf microtubule with MLi-2 present. Focused on the tetramer only. Sharpened.
Sample
  • Complex: LRRK2RCKW filament bound to a 11-pf microtubule with MLi-2 present.
    • Protein or peptide: C-terminal of Leucine Rich Repeat Kinase 2
    • Protein or peptide: Tubulin alpha
    • Protein or peptide: Tubulin beta
Keywordsparkinson's disease / microtubule / kinase / gtpase / CYTOSOLIC PROTEIN
Biological speciesHomo sapiens (human) / Bos taurus (cattle)
Methodsingle particle reconstruction / cryo EM / Resolution: 5.9 Å
AuthorsMatyszewski M / Leschziner AE
Funding support United States, 1 items
OrganizationGrant numberCountry
Other privateASAP-000519 United States
CitationJournal: Nat Struct Mol Biol / Year: 2022
Title: Structural basis for Parkinson's disease-linked LRRK2's binding to microtubules.
Authors: David M Snead / Mariusz Matyszewski / Andrea M Dickey / Yu Xuan Lin / Andres E Leschziner / Samara L Reck-Peterson /
Abstract: Leucine-rich repeat kinase 2 (LRRK2) is one of the most commonly mutated genes in familial Parkinson's disease (PD). Under some circumstances, LRRK2 co-localizes with microtubules in cells, an ...Leucine-rich repeat kinase 2 (LRRK2) is one of the most commonly mutated genes in familial Parkinson's disease (PD). Under some circumstances, LRRK2 co-localizes with microtubules in cells, an association enhanced by PD mutations. We report a cryo-EM structure of the catalytic half of LRRK2, containing its kinase, in a closed conformation, and GTPase domains, bound to microtubules. We also report a structure of the catalytic half of LRRK1, which is closely related to LRRK2 but is not linked to PD. Although LRRK1's structure is similar to that of LRRK2, we find that LRRK1 does not interact with microtubules. Guided by these structures, we identify amino acids in LRRK2's GTPase that mediate microtubule binding; mutating them disrupts microtubule binding in vitro and in cells, without affecting LRRK2's kinase activity. Our results have implications for the design of therapeutic LRRK2 kinase inhibitors.
History
DepositionDec 8, 2021-
Header (metadata) releaseDec 28, 2022-
Map releaseDec 28, 2022-
UpdateJan 17, 2024-
Current statusJan 17, 2024Processing site: RCSB / Status: Released

-
Structure visualization

Supplemental images

Downloads & links

-
Map

FileDownload / File: emd_25664.map.gz / Format: CCP4 / Size: 103 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES)
AnnotationLocal refinement of LRRK2RCKW tetramer bound to 11-pf microtubule with MLi-2 present. Focused on the tetramer only. Sharpened.
Voxel sizeX=Y=Z: 1.16 Å
Density
Contour LevelBy AUTHOR: 0.302
Minimum - Maximum-1.2475556 - 2.031491
Average (Standard dev.)0.0064139655 (±0.0717428)
SymmetrySpace group: 1
Details

EMDB XML:

Map geometry
Axis orderXYZ
Origin000
Dimensions300300300
Spacing300300300
CellA=B=C: 348.0 Å
α=β=γ: 90.0 °

-
Supplemental data

-
Mask #1

Fileemd_25664_msk_1.map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Additional map: Non-sharpened map

Fileemd_25664_additional_1.map
AnnotationNon-sharpened map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Half map: Half map 2

Fileemd_25664_half_map_1.map
AnnotationHalf map 2
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Half map: Half map 1

Fileemd_25664_half_map_2.map
AnnotationHalf map 1
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Sample components

-
Entire : LRRK2RCKW filament bound to a 11-pf microtubule with MLi-2 present.

EntireName: LRRK2RCKW filament bound to a 11-pf microtubule with MLi-2 present.
Components
  • Complex: LRRK2RCKW filament bound to a 11-pf microtubule with MLi-2 present.
    • Protein or peptide: C-terminal of Leucine Rich Repeat Kinase 2
    • Protein or peptide: Tubulin alpha
    • Protein or peptide: Tubulin beta

-
Supramolecule #1: LRRK2RCKW filament bound to a 11-pf microtubule with MLi-2 present.

SupramoleculeName: LRRK2RCKW filament bound to a 11-pf microtubule with MLi-2 present.
type: complex / ID: 1 / Parent: 0 / Macromolecule list: all
Details: Mask focused on LRRK2RCKW only. No microtubule present in this map.
Molecular weightTheoretical: 500 KDa

-
Macromolecule #1: C-terminal of Leucine Rich Repeat Kinase 2

MacromoleculeName: C-terminal of Leucine Rich Repeat Kinase 2 / type: protein_or_peptide / ID: 1 / Details: I2020T mutation Residues 1327-2527 of LRRK2 / Enantiomer: LEVO
Source (natural)Organism: Homo sapiens (human)
Recombinant expressionOrganism: Spodoptera frugiperda (fall armyworm)
SequenceString: KKAVPYNRMK LMIVGNTGSG KTTLLQQLMK TKKSDLGMQS ATVGIDVKDW PIQIRDKRKR DLVLNVWDF AGREEFYSTH PHFMTQRALY LAVYDLSKGQ AEVDAMKPWL FNIKARASSS P VILVGTHL DVSDEKQRKA CMSKITKELL NKRGFPAIRD YHFVNATEES ...String:
KKAVPYNRMK LMIVGNTGSG KTTLLQQLMK TKKSDLGMQS ATVGIDVKDW PIQIRDKRKR DLVLNVWDF AGREEFYSTH PHFMTQRALY LAVYDLSKGQ AEVDAMKPWL FNIKARASSS P VILVGTHL DVSDEKQRKA CMSKITKELL NKRGFPAIRD YHFVNATEES DALAKLRKTI IN ESLNFKI RDQLVVGQLI PDCYVELEKI ILSERKNVPI EFPVIDRKRL LQLVRENQLQ LDE NELPHA VHFLNESGVL LHFQDPALQL SDLYFVEPKW LCKIMAQILT VKVEGCPKHP KGII SRRDV EKFLSKKRKF PKNYMSQYFK LLEKFQIALP IGEEYLLVPS SLSDHRPVIE LPHCE NSEI IIRLYEMPYF PMGFWSRLIN RLLEISPYML SGRERALRPN RMYWRQGIYL NWSPEA YCL VGSEVLDNHP ESFLKITVPS CRKGCILLGQ VVDHIDSLME EWFPGLLEID ICGEGET LL KKWALYSFND GEEHQKILLD DLMKKAEEGD LLVNPDQPRL TIPISQIAPD LILADLPR N IMLNNDELEF EQAPEFLLGD GSFGSVYRAA YEGEEVAVKI FNKHTSLRLL RQELVVLCH LHHPSLISLL AAGIRPRMLV MELASKGSLD RLLQQDKASL TRTLQHRIAL HVADGLRYLH SAMIIYRDL KPHNVLLFTL YPNAAIIAKI ADYGTAQYCC RMGIKTSEGT PGFRAPEVAR G NVIYNQQA DVYSFGLLLY DILTTGGRIV EGLKFPNEFD ELEIQGKLPD PVKEYGCAPW PM VEKLIKQ CLKENPQERP TSAQVFDILN SAELVCLTRR ILLPKNVIVE CMVATHHNSR NAS IWLGCG HTDRGQLSFL DLNTEGYTSE EVADSRILCL ALVHLPVEKE SWIVSGTQSG TLLV INTED GKKRHTLEKM TDSVTCLYCN SFSKQSKQKN FLLVGTADGK LAIFEDKTVK LKGAA PLKI LNIGNVSTPL MCLSESTNST ERNVMWGGCG TKIFSFSNDF TIQKLIETRT SQLFSY AAF SDSNIITVVV DTALYIAKQN SPVVEVWDKK TEKLCGLIDC VHFLREVMVK ENKESKH KM SYSGRVKTLC LQKNTALWIG TGGGHILLLD LSTRRLIRVI YNFCNSVRVM MTAQLGSL K NVMLVLGYNR KNTEGTQKQK EIQSCLTVWD INLPHEVQNL EKHIEVRKEL AEKMRRTSV E

-
Macromolecule #2: Tubulin alpha

MacromoleculeName: Tubulin alpha / type: protein_or_peptide / ID: 2 / Enantiomer: LEVO
Source (natural)Organism: Bos taurus (cattle)
SequenceString: MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN TFFSETGAGK HVPRAVFVD LEPTVIDEVR TGTYRQLFHP EQLITGKEDA ANNYARGHYT IGKEIIDLVL D RIRKLADQ CTGLQGFLVF HSFGGGTGSG FTSLLMERLS VDYGKKSKLE ...String:
MRECISIHVG QAGVQIGNAC WELYCLEHGI QPDGQMPSDK TIGGGDDSFN TFFSETGAGK HVPRAVFVD LEPTVIDEVR TGTYRQLFHP EQLITGKEDA ANNYARGHYT IGKEIIDLVL D RIRKLADQ CTGLQGFLVF HSFGGGTGSG FTSLLMERLS VDYGKKSKLE FSIYPAPQVS TA VVEPYNS ILTTHTTLEH SDCAFMVDNE AIYDICRRNL DIERPTYTNL NRLIGQIVSS ITA SLRFDG ALNVDLTEFQ TNLVPYPRIH FPLATYAPVI SAEKAYHEQL SVAEITNACF EPAN QMVKC DPRHGKYMAC CLLYRGDVVP KDVNAAIATI KTKRTIQFVD WCPTGFKVGI NYQPP TVVP GGDLAKVQRA VCMLSNTTAI AEAWARLDHK FDLMYAKRAF VHWYVGEGME EGEFSE ARE DMAALEKDYE EVGVDSVEGE GEEEGEEY

-
Macromolecule #3: Tubulin beta

MacromoleculeName: Tubulin beta / type: protein_or_peptide / ID: 3 / Enantiomer: LEVO
Source (natural)Organism: Bos taurus (cattle)
SequenceString: MREIVHIQIG QCGNQIGAKF WEVIGEEHGI DWAGSYCGDS ALQLERISVY YNEAHGKKYV PRAVLVDLE PGTMDSIRSS RVGALFQPDS FVHGNSGAGN NWAKGYYTEG AELVDRVLDA V RTEAEGCD CLQGFQLVHS LGGGTGSGMG TLLLGKIREE YPDRILNSFS ...String:
MREIVHIQIG QCGNQIGAKF WEVIGEEHGI DWAGSYCGDS ALQLERISVY YNEAHGKKYV PRAVLVDLE PGTMDSIRSS RVGALFQPDS FVHGNSGAGN NWAKGYYTEG AELVDRVLDA V RTEAEGCD CLQGFQLVHS LGGGTGSGMG TLLLGKIREE YPDRILNSFS VMPSPKVSDT VV EPYNAVL ALHQLVLNSD ACFCIDNEAL YDICFRTLRL STPTYGDLNH LVSLTMSGIT TSL RFPGQL NADLRKLAVN MVPFPRLHFF MPGFAPLTAQ GSQQYRALTV AELTQQMFDA RNTM AACDP RRGRYLTVAC IFRGRMSTKE VDEQLLNVQT RNSSCFVEWI PNNVKVAVCD IPPRG LSMA ATFIGNNTAI QELFSRISEH FSAMFKRKAF VHWYTGEGMD INEFTEAESN IQDLVS EYQ QFQDARADVE EEEIGGEAEV EPADKEH

-
Experimental details

-
Structure determination

Methodcryo EM
Processingsingle particle reconstruction
Aggregation statefilament

-
Sample preparation

BufferpH: 7.4
Component:
ConcentrationNameFormula
20.0 mMHEPES
80.0 mMSodium ChlorideNaClSodium chloride
0.5 mMTCEP
2.5 mMMagnesium ChlorideMgCl2
20.0 uMGDP

Details: This is the final dilution buffer. The incubation buffer consisted of 1x BRB80, 10% glycerol, 1mM DTT, 1mM GTP, 1mM MgCl2, 10 uM taxol, and 5 uM MLi-2. Sample was diluted 3-fold right before ...Details: This is the final dilution buffer. The incubation buffer consisted of 1x BRB80, 10% glycerol, 1mM DTT, 1mM GTP, 1mM MgCl2, 10 uM taxol, and 5 uM MLi-2. Sample was diluted 3-fold right before freezing with the final buffer.
GridModel: EMS Lacey Carbon / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Support film - topology: LACEY / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 45 sec. / Details: EMS (LC-300)
VitrificationCryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K
Details4.5 uM of LRRK2RCKW was allowed to incubate with 2.25 uM of tubulin dimer, causing both to co-polymerize. 5 uM of MLi-2 was present as well. The sample was diluted 3-fold right before freezing (1.5 uM LRRK2RCKW concentration final).

-
Electron microscopy

MicroscopeFEI TALOS ARCTICA
Electron beamAcceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN
Electron opticsC2 aperture diameter: 70.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELDBright-field microscopy / Cs: 2.7 mm / Nominal defocus max: 1.5 µm / Nominal defocus min: 1.5 µm / Nominal magnification: 36000
Sample stageCooling holder cryogen: NITROGEN
Image recordingFilm or detector model: GATAN K2 SUMMIT (4k x 4k) / Detector mode: COUNTING / Number grids imaged: 2 / Average exposure time: 10.0 sec. / Average electron dose: 55.0 e/Å2 / Details: 250 ms frames
Experimental equipment
Model: Talos Arctica / Image courtesy: FEI Company

-
Image processing

Particle selectionNumber selected: 557577
Details: Filament Autopicker with templates created by manual picking. This is the count before symmetry expansion.
Startup modelType of model: NONE
Details: Featureless cylinder for the original helical reconstruction, then subunit from the helical reconstruction after reboxing and symmetry expansion.
Initial angle assignmentType: NOT APPLICABLE
Final angle assignmentType: NOT APPLICABLE
Final reconstructionApplied symmetry - Point group: C1 (asymmetric) / Resolution.type: BY AUTHOR / Resolution: 5.9 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cryoSPARC (ver. 3.0)
Software - details: local refinement, with non-uniform refinement turned off
Details: Local refinement focusing only on the tetramer of LRRK2RCKW
Number images used: 133246
FSC plot (resolution estimation)

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more